Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus May Boost Policy Efforts To Enhance US Drug, Medical Supply Production

Mar 03 2020

• By Derrick Gingery

United States Capitol Building in Washington DC USA — FDA officials are determining whether API export restrictions imposed in India will affect the US drug supply. • Source: File photo

Related Content

For Coronavirus, US FDA Is At The Podium But Not On The Task Force

Feb 10 2020

Market For COVID-19 Therapeutics Will Exceed Government Demand, US Believes

Feb 25 2020

Mylan Weighs In On Coronavirus Drug Shortage Concerns

Feb 28 2020

Drug Shortages Loom If Coronavirus Persists In China, Generics Execs Say

Feb 26 2020

US Biopharma ‘Consortium’ Promises Array Of Coronavirus Remedies

Mar 04 2020

New CDER Lab Will Help Push Advanced Manufacturing Adoption

Mar 03 2020

Related Companies

Gilead Sciences, Inc.

Moderna, Inc.

Additional Topics

United States Manufacturing Legislation Regulation Vaccines FDA Coronavirus COVID-19 Infectious Diseases BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window